Initial laboratory investigations revealed neutrophilic leukocytosis, hyponatremia and hyperkalemia (Table 2).  Investigations were appreciative of an infectious process along with newly-diagnosed Type 2 diabetes mellitus and diabetic ketoacidosis (DKA). The patient was commenced on DKA protocol and empirically started on ceftriaxone plus vancomycin, which was later escalated to meropenem. He underwent right anterior chamber tap, vitreous tap and intracameral and intravitreal injection with vancomycin, ceftazidime, and voriconazole.